A new understanding of how enzymes influence bacterial protein production
Novel research expands scientific understanding of how RNA shapes the reading of genetic information.
Antimicrobial resistance poses a significant global health threat, with bacteria rapidly evolving to resist existing treatments. A recent study by an international team of scientists has identified aminovaleramididine synthetase (AvaS), a previously unknown pyridoxal phosphate (PLP)-dependent enzyme, that plays a crucial role in a chemical modification linked to bacterial protein production.
This discovery provides new insights into how bacteria adapt to stress and could lead to the development of novel antimicrobial therapeutics.
The research, led by scientists from the Singapore-MIT Alliance for Research and Technology's Antimicrobial Resistance research group (SMART AMR) and published in Nature Chemical Biology, focuses on tRNA, a specialized type of RNA that helps bacteria control protein synthesis in response to various conditions, including antibiotic exposure. AvaS was discovered in Pseudomonas aeruginosa, a bacterium responsible for severe infections like pneumonia and sepsis.
Using a high-throughput screening platform, the researchers identified AvaS in P. aeruginosa and confirmed its presence in other bacteria, such as Acinetobacter baumannii and Vibrio cholerae, as well as the plant Arabidopsis thaliana. The enzyme uses PLP, a derivative of vitamin B6, to convert lysidine into aminovaleramide cytidine (ava 2 C), a novel modification in tRNA.
The discovery of AvaS and its role in modifying tRNA expands the known functions of PLP-dependent enzymes, which are primarily associated with amino acid metabolism. This finding demonstrates that PLP-dependent enzymes can directly modify tRNA, leading to faster and more efficient protein production and helping bacteria adapt to metabolic and oxidative stress.
The implications of this research are far-reaching, as it opens new avenues for studying bacterial adaptation and the development of antimicrobial strategies. The team plans to investigate how ava 2 C affects bacterial stress responses and metabolism, with the ultimate goal of uncovering novel ways to combat drug-resistant bacteria and develop future antimicrobial therapeutics.
The findings also suggest that other organisms might employ similar biological tools to produce chemical modifications, potentially influencing protein synthesis across various life forms.
Written by urgent.news from MIT News Research's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
